Contract Capabilities Hercon Laboratories offers contract development and scale-up of transdermal formulations in addition to manufacturing, presenting a growth channel for CDMO services to potential pharma and biotech partners seeking early-stage formulation support and scale-up expertise.

Transdermal Niche Specialization in transdermal nitroglycerin patches positions the company for ongoing demand in cardiovascular therapies and niche dermatological delivery, suggesting cross-sell opportunities to firms developing patch-based or combination therapies.

Smaller Scale Agility With a lean team and revenue in the low millions, there is a selling point around agility, faster decision cycles, and personalized customer service for small-to-mid market pharma companies seeking rapid prototyping, small-batch production, or urgent manufacturing contingencies.

Full Service CDMO The blend of manufacturing and development capabilities can be promoted as a turnkey solution for clients wanting end-to-end support from formulation design through scale-up, reducing vendor coordination and timelines.

Growth Potential Revenue visibility and potential expansion into broader transdermal portfolios or additional contract work could be unlocked by targeting emerging biotech startups and mid-sized pharma players needing specialized patch technologies and regulatory-compliant manufacturing.